Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Progression-related outcomes of teriflunomide in multiple sclerosis clinical trials.
Discriminative Abilities of Macular and Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis and Optic Neuritis.
Effectiveness of dual-task training on balance and gait in people with multiple sclerosis: a systematic review and meta-analysis.
Benefits of cannabis in treating lower urinary tract symptoms: A scoping review.
The multifactorial nature of reproductive decision-making among women with multiple sclerosis.
Cesarean sections prior to 39 weeks among pregnant patients with multiple sclerosis.
Brain-wide magnetic resonance imaging analysis of neurobehavioral comorbidities in temporal lobe epilepsy.
Untangling prognosis in multiple sclerosis.
A Lactate-H4K12la-HDAC1 epigenetic axis governs microglial state transitions during experimental autoimmune encephalomyelitis in female mice.
SKYSCRAPER-05: A Phase 2 Study of Perioperative Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Patients With Previously Untreated, Locally Advanced, Resectable, Stage II‒IIIB NSCLC.
Spatiotemporal Heterogeneity of Sulfatide Molecular Species During Schwann Cell Development in the Peripheral Nervous System.
Glymphatic dysfunction and myelin disruption in subthreshold depression.
When does distress disclosure help? Anticipated stigma and the moderating role of perceived social support in depression and anxiety among individuals with multiple sclerosis.
[Acute unilateral loss of vision with retrobulbar pain in a patient with known multiple sclerosis-A clear diagnosis?].
Rituximab With or Without Chemotherapy for Anti-MAG Neuropathy: A Retrospective Multicenter Real-World Study.
Myelin oligodendrocyte glycoprotein antibody-associated disease in a patient with AIRE gene dominant-negative mutation.
Neuromyelitis optica spectrum disorder associated with Kabuki syndrome: First reported case and immunopathogenic considerations.
Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials.
Dual-responsive carbon dot probe utilizing proton exchange and aggregation for correlating biomarker levels with postherpetic neuralgia.
Clinical, Radiological, and Prognostic Features of Pediatric Clinically Isolated Syndrome and Risk of Conversion to Multiple Sclerosis: A Single-center Cohort Study.
Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.
Isolated Cytomegalovirus Optic Neuritis in an Immunocompetent Patient.
"All anti-CD20 therapies are equivalent in treating MS": Commentary.
Regional IVIM-DWI Abnormalities in Normal-Appearing White Matter and Lesion Tissue in Relapsing-Remitting Multiple Sclerosis.
Evaluation of oxidative stress and coagulation factors in MS patients throughout both relapse and remission stages.

Pages